SIG
Sargent Investment Group’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $349K | Sell |
4,050
-80
| -2% | -$6.89K | 0.05% | 181 |
|
|
2025
Q1 | $335K | Sell |
4,130
-340
| -8% | -$27.6K | 0.05% | 179 |
|
|
2024
Q4 | $398K | Sell |
4,470
-180
| -4% | -$16K | 0.07% | 158 |
|
|
2024
Q3 | $459K | Hold |
4,650
| – | – | 0.08% | 127 |
|
|
2024
Q2 | $431K | Buy |
4,650
+450
| +11% | +$41.7K | 0.09% | 129 |
|
|
2024
Q1 | $399K | Sell |
4,200
-70
| -2% | -$6.64K | 0.09% | 130 |
|
|
2023
Q4 | $381K | Sell |
4,270
-530
| -11% | -$47.3K | 0.08% | 138 |
|
|
2023
Q3 | $350K | Hold |
4,800
| – | – | 0.08% | 143 |
|
|
2023
Q2 | $399K | Hold |
4,800
| – | – | 0.1% | 127 |
|
|
2023
Q1 | $370K | Hold |
4,800
| – | – | 0.1% | 130 |
|
|
2022
Q4 | $398K | Sell |
4,800
-600
| -11% | -$49.8K | 0.12% | 126 |
|
|
2022
Q3 | $446K | Buy |
5,400
+1,060
| +24% | +$87.5K | 0.14% | 113 |
|
|
2022
Q2 | $322K | Buy |
4,340
+250
| +6% | +$18.5K | 0.1% | 136 |
|
|
2022
Q1 | $368K | Buy |
4,090
+460
| +13% | +$41.4K | 0.09% | 135 |
|
|
2021
Q4 | $406K | Buy |
3,630
+90
| +3% | +$10.1K | 0.09% | 134 |
|
|
2021
Q3 | $445K | Hold |
3,540
| – | – | 0.11% | 127 |
|
|
2021
Q2 | $479K | Hold |
3,540
| – | – | 0.11% | 124 |
|
|
2021
Q1 | $480K | Hold |
3,540
| – | – | 0.13% | 120 |
|
|
2020
Q4 | $498K | Hold |
3,540
| – | – | 0.16% | 105 |
|
|
2020
Q3 | $394K | Sell |
3,540
-300
| -8% | -$33.4K | 0.14% | 111 |
|
|
2020
Q2 | $432K | Buy |
3,840
+225
| +6% | +$25.3K | 0.16% | 101 |
|
|
2020
Q1 | $280K | Hold |
3,615
| – | – | 0.13% | 111 |
|
|
2019
Q4 | $344K | Hold |
3,615
| – | – | 0.13% | 113 |
|
|
2019
Q3 | $276K | Hold |
3,615
| – | – | 0.12% | 116 |
|
|
2019
Q2 | $317K | Hold |
3,615
| – | – | 0.14% | 116 |
|
|
2019
Q1 | $327K | Hold |
3,615
| – | – | 0.16% | 103 |
|
|
2018
Q4 | $259K | Buy |
+3,615
| New | +$259K | 0.16% | 104 |
|